Craft

AddLife

Stock Price

KR139

2024-10-29

Market Capitalization

KR16.9 B

2024-10-29

Revenue

KR10.4 B

FY, 2025

AddLife Summary

Company Summary

Overview
AddLife provides products, services, and advisory services to life science companies. The Company operates through Labtech and Medtech segments. The Labtech segment provides various products and solutions, including analysis instruments, equipment, microscopes, consumables and reagents, as well as application and technical services primarily to laboratories in medicine, research, academia, food, pharmaceutical, microbiology, clinical chemistry, coagulation, molecular biology, immunology, point-of-care testing, and veterinary diagnostics industries. This segment also offers training programs, seminars, and advisory services. The Medtech segment provides medical device products to various markets, such as surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, home healthcare, surgical equipment, thoracic surgery, and laboratory.
Type
Public
Status
Active
Founded
2015
HQ
Stockholm, SE | view all locations
Website
https://www.add.life/en/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Stefan Hedelius

    Stefan Hedelius, Director

    • Johan Sjö

      Johan Sjö, Chairman of the Board

      • Kristina Willgård

        Kristina Willgård, CEO

        • Martin Almgren

          Martin Almgren, CFO

          LocationsView all

          1 location detected

          • Stockholm, Stockholms län HQ

            Sweden

            Brunkebergstorg 5

          AddLife Financials

          Summary Financials

          Revenue (Q1, 2026)
          kr2.6B
          Gross profit (Q1, 2026)
          kr1.2B
          Net income (Q1, 2026)
          kr128.0M
          Cash (Q1, 2026)
          kr771.0M
          EBIT (Q1, 2026)
          kr229.0M
          Enterprise value
          $21.0B

          Footer menu